This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

'Fast Money' Recap: Next Stop, S&P 2,100?

Robyn Karnauskas, biotechnology analyst at Deutsche Bank, said the big theme among biotech companies is creating drugs that address big markets, such as the different liver diseases. She likes Achillion Pharmaceuticals (ACHN) , which is developing treatments for Hepatitis C. A similar peer to ACHN is Idenix Pharmaceuticals (IDIX) , which was recently purchased by Merck (MRK)

She also likes Intercept Pharmaceuticals (ICPT) , which is developing a treatment for nonalcoholic steatohepatitis. Arrowhead Research (ARWR) could also be an attractive takeover target if its Hepatitis B drug data, which is scheduled to be released this fall, is positive. 

Najarian said stocks like Amgen (AMGN) and Celgene have reasonable valuations and strong growth. He likes them on the long side. 

Grasso reminded investors that biotech stocks can be volatile. He suggested using the iShares Nasdaq Biotechnology ETF (IBB) to diversify the risks. 

Amazon (AMZN) announced that it will purchase Twitch for $970 million. Grasso said he likes the company's move into the gaming and video segment. 

Burger King Worldwide (BKW) is in talks to purchase Tim Hortons (THI) and both stocks climbed roughly 20%. Seymour said this is a great deal for Tim Hortons and will benefit Burger King from a tax perspective. Najarian said it will help BKW boost its breakfast and coffee segments as well its exposure in Canada. 

Adami said he still finds Burger King cheap, even after Monday's rally. If forced to choose between Burger King and McDonald's (MCD) as investment, Grasso is a buyer of McDonald's. 

Dennis Gartman, editor and publisher of The Gartman Letter, was a guest on the show. Despite WTI crude prices falling 12% in the past two months, he said there is more downside ahead, possibly to $85. Until the front month contracts stop trading at lower prices than the back month contracts, the commodity is unlikely to rally. 

However, Gartman is a buyer of natural gas, saying that bad news is no longer sending the commodity lower -- a sign that a bottom has been put in. He argued that below $4.00 BTU, natural gas seems attractive. Turning to soft commodities, he said grain rallies should be sold. But due to the bountiful harvest, consumer should enjoy lower meat and crop prices in the future. 

Read More: Galena Fires CEO Ahn, Offers No Parting Gifts

Najarian said companies that have both oil and gas operations may be able to withstand falling crude oil prices. 

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs